IDEAYA Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

• IDEAYA Biosciences Inc IDYA.OQ reported a quarterly adjusted loss of $1.49​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -52 cents. The mean expectation of thirteen analysts for the quarter was for a loss of 64 cents per share. Wall Street expected results to range from -73 cents to -41 cents per share.

• Revenue rose 78.4% to $7.00 million from a year ago; analysts expected $4.67 million.

• IDEAYA Biosciences Inc's reported EPS for the quarter was a loss of $1.49​.

• The company reported a quarterly loss of $130.31 million.

• IDEAYA Biosciences Inc shares had fallen by 18.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for IDEAYA Biosciences Inc is $52.00

This summary was machine generated from LSEG data February 18 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)